Thrivent Financial for Lutherans’s VanEck Pharmaceutical ETF PPH Stock Holding History

Thrivent Financial for Lutherans’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.14M	Buy	20,642 +5,548	+37%	+$591K	﹤0.01%	1387
2025 Q4	$1.56M	Buy	+15,094	New	+$1.47M	﹤0.01%	1636
2025 Q3	–	Sell	-20,681	Closed	-$1.82M	–	2556
2025 Q2	$1.82M	Buy	+20,681	New	+$1.79M	﹤0.01%	1416
2025 Q1	–	Sell	-153,063	Closed	-$13.2M	–	2503
2024 Q4	$13.2M	Sell	153,063 -81,827	-35%	-$7.4M	0.03%	575
2024 Q3	$22.3M	Buy	234,890 +59,025	+34%	+$5.61M	0.04%	437
2024 Q2	$16.1M	Buy	+175,865	New	+$15.7M	0.03%	515

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Thrivent Financial for Lutherans's PPH Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its VanEck Pharmaceutical ETF (PPH) stake by 37% in Q1 2026, buying an estimated $591K and bringing the position to 20,642 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Thrivent Financial for Lutherans first reported a position in PPH in Q2 2024 and has held it in 6 quarters since. The position peaked at $22.3M in Q3 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Thrivent Financial for Lutherans held 20,642 shares of VanEck Pharmaceutical ETF worth $2.14M as of Q1 2026.
Thrivent Financial for Lutherans bought 5,548 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $591K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1387 holding.
Thrivent Financial for Lutherans first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 6 quarters since.
Thrivent Financial for Lutherans's VanEck Pharmaceutical ETF position peaked at $22.3M in Q3 2024.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.